✦ LIBER ✦

W1331 Effect of Itraconazole on Inflammatory Bowel Disease Activity in Patients Treated for Histoplasmosis

✍ Scribed by Samuel, Sunil; Loftus, Edward V.; Hanson, Karen A.; Sandborn, William J.

Book ID: 122802835
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 86 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63222-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of itraconazole on inflammat

The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis

✍ S. Samuel; E. V. Loftus Jr; W. J. Sandborn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

P080 Effect of chondroitin sulphate on p

P080 Effect of chondroitin sulphate on pro-inflammatory mediators and disease activity in patients with inflammatory bowel disease (IBD)

✍ Linares, P.M.; Chaparro, M.; Algaba, A.; Guerra, I.; Román, M.; Moreno Arza, I.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Tu1704 Effect of Chondroitin Sulphate on

Tu1704 Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients With Inflammatory Bowel Disease (IBD)

✍ Linares, Pablo M.; Chaparro, Maria; Algaba, Alicia; Román, Manuel; Arza, M. Isab 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P081 Effect of condroitin sulphate on pr

P081 Effect of condroitin sulphate on pro-inflammatory mediators and disease activity in patients with inflammatory bowel disease (IBD)

✍ Linares, P.M.; Chaparro, M.; Algaba, A.; Román, M.; Moreno Arza, I.; Abad Santos 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 66 KB

Quantification of disease activity in pa

Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease

✍ Heok K. Cheow; Demetrius D. Voutnis; John W. Evans; Katy R. Szczepura; E. Anna S 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 544 KB

Presentation and outcome of histoplasmos

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

✍ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection